XHKG
1289
Market cap35mUSD
Jul 10, Last price
2.06HKD
1D
-4.19%
1Q
-15.57%
Jan 2017
-37.95%
IPO
-83.83%
Name
Wuxi Sunlit Science and Technology Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Wuxi Sunlit Science and Technology Company Limited offers a comprehensive suite of services to the steel wire product manufacturing sector across the People's Republic of China. Its core activities encompass the entire lifecycle of specialized production lines, from initial research and development and design to manufacturing, equipment supply, installation, testing, repair, and ongoing maintenance. The company's extensive product range includes various production lines for specific applications, such as brass electroplating wire, bead wire, pre-treatment processes, inter-medium heat treatment, and both hot dip and electro galvanizing. Beyond these complete systems, Wuxi Sunlit also provides individual components and machinery. This includes gas furnaces, water quenching baths, lead baths designed for heat treatment, advanced diffusion induction heating systems, take-up and pay-off mechanisms, and acid mist scrubbers. Furthermore, it supplies specialized equipment like wire bunching, wire drawing, wrapping, and die repair machines. In addition to its primary manufacturing focus, Wuxi Sunlit is also involved in the trading of machinery products. The company actively participates in software development and the commercialization of software patent rights. The products developed by Wuxi Sunlit find broad application across numerous industrial sectors, contributing to the production of items such as radial tire steel cords, bead wires, cutting wires, hose wires, precision wire ropes, and a wide array of other steel wire derivatives. Founded in 2006, the company is headquartered in Wuxi, located in the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||